Top

Published in:

01-07-2017 | SSIEM 2016

Recent advances in liver transplantation for metabolic disease

Author: P. J. Mc Kiernan

Published in: Journal of Inherited Metabolic Disease | Issue 4/2017

Abstract

The indications and outcomes of liver transplantation for metabolic disease have been reviewed recently and this short review concentrates on recent developments and advances. Recently recognized metabolic causes of acute liver failure are reviewed and their implications for transplantation discussed. Newly described indications for liver transplantation in systemic metabolic diseases are described and an update is given on the role of auxiliary and domino liver transplantation.

Boschetti E, D’Alessandro R, Bianco F, Carelli V, Cenacchi G, Pinna AD, Del Gaudio M, Rinaldi R, Stanghellini V, Pironi L, Rhoden K, Tugnoli V, Casali C, De Giorgio R (2014) Liver as a source for thymidine phosphorylase replacement in mitochondrial neurogastrointestinal encephalomyopathy. PLoS One 9(5):e96692CrossRefPubMedPubMedCentral

Celik N, Squires RH, Vockley J, Sindhi R, Mazariegos G (2016) Liver transplantation for maple syrup urine disease: A global domino effect. Pediatr Transplant 20(3):350–351CrossRefPubMed

De Giorgio R, Pironi L, Rinaldi R, Boschetti E, Caporali L, Capristo M, Casali C, Cenacchi G, Contin M, D’Angelo R, D’Errico A, Gramegna LL, Lodi R, Maresca A, Mohamed S, Morelli MC, Papa V, Tonon C, Tugnoli V, Carelli V, D’Alessandro R, Pinna AD (2016) Liver transplantation for mitochondrial neurogastrointestinal encephalomyopathy. Ann Neurol 80(3):448–455CrossRefPubMed

Dias RP, Buchanan CR, Thomas N, Lim S, Solanki G, Connor SE, Barrett TG, Kapoor RR (2016) Os odontoideum in wolcott-rallison syndrome: a case series of 4 patients. Orphanet J Rare Dis 11:14CrossRefPubMedPubMedCentral

Dionisi-Vici C, Diodato D, Torre G, Picca S, Pariante R, Giuseppe Picardo S, Di Meo I, Rizzo C, Tiranti V, Zeviani M, De Ville De Goyet J (2016) Liver transplant in ethylmalonic encephalopathy: a new treatment for an otherwise fatal disease. Brain 139(Pt 4):1045–1051CrossRefPubMed

Govil S, Shanmugam NP, Reddy MS, Narasimhan G, Rela M (2015) A metabolic chimera: two defective genotypes make a normal phenotype. Liver Transpl 21(11):1453–1454

Haack TB, Staufner C, Kopke MG, Straub BK, Kolker S, Thiel C, Freisinger P, Baric I, McKiernan PJ, Dikow N, Harting I, Beisse F, Burgard P, Kotzaeridou U, Kuhr J, Himbert U, Taylor RW, Distelmaier F, Vockley J, Ghaloul-Gonzalez L, Zschocke J, Kremer LS, Graf E, Schwarzmayr T, Bader DM, Gagneur J, Wieland T, Terrile C, Strom TM, Meitinger T, Hoffmann GF, Prokisch H (2015) Biallelic mutations in NBAS cause recurrent acute liver failure with onset in infancy. Am J Hum Genet 97(1):163–169

Habeb AM, Al-Magamsi MS, Eid IM, Ali MI, Hattersley AT, Hussain K, Ellard S (2012) Incidence, genetics, and clinical phenotype of permanent neonatal diabetes mellitus in northwest Saudi Arabia. Pediatr Diabetes 13(6):499–505CrossRefPubMed

Halter JP, Michael W, Schupbach M, Mandel H, Casali C, Orchard K, Collin M, Valcarcel D, Rovelli A, Filosto M, Dotti MT, Marotta G, Pintos G, Barba P, Accarino A, Ferra C, Illa I, Beguin Y, Bakker JA, Boelens JJ, de Coo IF, Fay K, Sue CM, Nachbaur D, Zoller H, Sobreira C, Pinto Simoes B, Hammans SR, Savage D, Marti R, Chinnery PF, Elhasid R, Gratwohl A, Hirano M (2015) Allogeneic haematopoietic stem cell transplantation for mitochondrial neurogastrointestinal encephalomyopathy. Brain 138(Pt 10):2847–2858CrossRefPubMedPubMedCentral

Hynynen J, Komulainen T, Tukiainen E, Nordin A, Arola J, Kalviainen R, Jutila L, Roytta M, Hinttala R, Majamaa K, Makisalo H, Uusimaa J (2014) Acute liver failure after valproate exposure in patients with POLG1 mutations and its prognosis after liver transplantation. Liver Transpl 20(11):1402–1412CrossRefPubMed

Khanna A, Gish R, Winter SC, Nyhan WL, Barshop BA (2016) Successful domino liver transplantation from a patient with methylmalonic acidemia. JIMD Rep 25:87–94

Lee WS, McKiernan P, Kelly DA (2005) Etiology, outcome and prognostic indicators of childhood fulminant hepatic failure in the United Kingdom. J Pediatr Gastroenterol Nutr 40(5):575–581

Matsunami M, Shimozawa N, Fukuda A, Kumagai T, Kubota M, Chong PF, Kasahara M (2016) Living-donor liver transplantation from a heterozygous parent for infantile Refsum disease. Pediatrics 137:(6). doi: 10.1542/peds.2015-3102

Mazariegos G, Shneider B, Burton B, Fox IJ, Hadzic N, Kishnani P, Morton DH, McIntire S, Sokol RJ, Summar M, White D, Chavanon V, Vockley J (2014) Liver transplantation for pediatric metabolic disease. Mol Genet Metab 111(4):418–427CrossRefPubMed

McFarland R, Hudson G, Taylor RW, Green SH, Hodges S, McKiernan PJ, Chinnery PF, Ramesh V (2008) Reversible valproate hepatotoxicity due to mutations in mitochondrial DNA polymerase gamma (POLG1). Arch Dis Child 93(2):151–153CrossRefPubMed

McKiernan P (2014) Acute liver failure after valproate exposure: liver transplantation may be indicated beyond childhood. Liver Transpl 20(11):1287–1289

Mindikoglu AL, King D, Magder LS, Ozolek JA, Mazariegos GV, Shneider BL (2011) Valproic acid-associated acute liver failure in children: case report and analysis of liver transplantation outcomes in the United States. J Pediatr 158(5):802–807CrossRefPubMed

Popescu I, Dima SO (2012) Domino liver transplantation: how far can we push the paradigm? Liver Transpl 18(1):22–28CrossRefPubMed

Puppi J, Strom SC, Hughes RD, Bansal S, Castell JV, Dagher I, Ellis EC, Nowak G, Ericzon BG, Fox IJ, Gomez-Lechon MJ, Guha C, Gupta S, Mitry RR, Ohashi K, Ott M, Reid LM, Roy-Chowdhury J, Sokal E, Weber A, Dhawan A (2012) Improving the techniques for human hepatocyte transplantation: report from a consensus meeting in London. Cell Transplant 21(1):1–10CrossRefPubMed

Rela M, Muiesan P, Vilca-Melendez H, Dhawan A, Baker A, Mieli-Vergani G, Heaton ND (1999) Auxiliary partial orthotopic liver transplantation for Crigler-Najjar syndrome type I. Ann Surg 229(4):565–569CrossRefPubMedPubMedCentral

Rela M, Bharathan A, Palaniappan K, Cherian PT, Reddy MS (2015) Portal flow modulation in auxiliary partial orthotopic liver transplantation. Pediatr Transplant 19(3):255–260CrossRefPubMed

Rivera E, Gupta S, Chavers B, Quinones L, Berger MR, Schwarzenberg SJ, Pruett T, Verghese P, Chinnakotla S (2016) En bloc multiorgan transplant (liver, pancreas, and kidney) for acute liver and renal failure in a patient with Wolcott-Rallison syndrome. Liver Transpl 22(3):371–374CrossRefPubMed

Staufner C, Haack TB, Kopke MG, Straub BK, Kolker S, Thiel C, Freisinger P, Baric I, McKiernan PJ, Dikow N, Harting I, Beisse F, Burgard P, Kotzaeridou U, Lenz D, Kuhr J, Himbert U, Taylor RW, Distelmaier F, Vockley J, Ghaloul-Gonzalez L, Ozolek JA, Zschocke J, Kuster A, Dick A, Das AM, Wieland T, Terrile C, Strom TM, Meitinger T, Prokisch H, Hoffmann GF (2016) Recurrent acute liver failure due to NBAS deficiency: phenotypic spectrum, disease mechanisms, and therapeutic concepts. J Inherit Metab Dis 39(1):3–16CrossRefPubMed

Stephenne X, Debray FG, Smets F, Jazouli N, Sana G, Tondreau T, Menten R, Goffette P, Boemer F, Schoos R, Gersting SW, Najimi M, Muntau AC, Goyens P, Sokal EM (2012) Hepatocyte transplantation using the domino concept in a child with tetrabiopterin nonresponsive phenylketonuria. Cell Transplant 21(12):2765–2770CrossRefPubMed

Strauss KA, Ferreira C, Bottiglieri T, Zhao X, Arning E, Zhang S, Zeisel SH, Escolar ML, Presnick N, Puffenberger EG, Vugrek O, Kovacevic L, Wagner C, Mazariegos GV, Mudd SH, Soltys K (2015) Liver transplantation for treatment of severe S-adenosylhomocysteine hydrolase deficiency. Mol Genet Metab 116(1-2):44–52CrossRefPubMed

Thomson MA, Lynch S, Strong R, Shepherd RW, Marsh W (2000) Orthotopic liver transplantation with poor neurologic outcome in valproate-associated liver failure: a need for critical risk-benefit appraisal in the use of valproate. Transplant Proc 32(1):200–203CrossRefPubMed

Tzakis AG, Nunnelley MJ, Tekin A, Buccini LD, Garcia J, Uchida K, Neville HL, Nares MA, Ruiz P, Bodamer O (2015) Liver, pancreas and kidney transplantation for the treatment of Wolcott-Rallison syndrome. Am J Transplant 15(2):565–567CrossRefPubMed

Van Maldergem L, Moser AB, Vincent MF, Roland D, Reding R, Otte JB, Wanders RJ, Sokal E (2005) Orthotopic liver transplantation from a living-related donor in an infant with a peroxisome biogenesis defect of the infantile Refsum disease type. J Inherit Metab Dis 28(4):593–600CrossRefPubMed

Title: Recent advances in liver transplantation for metabolic disease
Author: P. J. Mc Kiernan
Publication date: 01-07-2017
Publisher: Springer Netherlands
Published in: Journal of Inherited Metabolic Disease / Issue 4/2017
Print ISSN: 0141-8955
Electronic ISSN: 1573-2665
DOI: https://doi.org/10.1007/s10545-017-0020-z

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Recent advances in liver transplantation for metabolic disease

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 4/2017

Cysteamine revisited: repair of arginine to cysteine mutations

Molecular therapy of primary hyperoxaluria

News and views

Role of miRNAs in human disease and inborn errors of metabolism

Hyperinsulinemic hypoglycemia: clinical, molecular and therapeutical novelties

High-content drug screening for rare diseases

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page